NeuRo Symposium 2026

This event is the kick-off for a Roche-hosted series of Symposia, dedicated to Neurology, The NeuRo Symposium will host speakers and leading customers in the field of Neuroscience from across the world and facilitate exchange among the participants. Roche aims to leveraging the momentum built via break-throughs in diagnostics and therapies in Alzheimer's disease as well as other neurological conditions such as traumatic brain injury and multiple sclerosis to foster vivid exchanges on key topics between renowned experts and interested customers.

Welcome and Introduction

Patient perspective - This session will fearure  powerful patient perspectives that highlight the real-world impact of Alzheimer’s disease
Peter Berry (UK)

Poster Walks

Clinical utility and implementation - This session will highlight the impact of AD biomarkers in clinical practice
Prof. Craig Ritchie (UK), Dr. Kristian Steen Frederiksen (Denmark), Prof. Mari DeMarco (St. Paul’s Hospital, Canada), Christopher Rowe (Australia)

Clinical and technical performance - This session will feature data and information on the clinical & technical performance of blood-based biomarkers focusing on pTau217
Prof. Henrik Zetterberg (Sweden), Prof. Marc Suarez (Spain), Dr. Alicia Algeciras (USA), Prof. Giovanni Frisoni (CH)

Beyond Alzheimer’s disease - Discussion about  blood-based biomarkers that are used in neurological diseases beyond AD
Prof. Henrik Zetterberg (Sweden), Prof. Marc Suarez (Spain), Sharmilee Gnanapavan (UK) TBI - Alfonso Lagares

Closing

Engage in scientific and pracitcal topics with experts in Neuroscience, covering Alzheimer's disease, traumatic brain injury, multiple sclerosis and Parkinson's disease.